APPLICATION OF THE PRINCIPAL COMPONENT ANALYSIS TO IR SPECTRA OF BLOOD SERUM OF PATIENTS WITH ONCOHEMATOLOGICAL DISEASES
Author:
Butyaev R.1, Chernyshev D.1, Mikhailets E.1, Plotnikova L.1, Garifullin A.2, Kuvshinov A.2, Voloshin S.2, Polyanichko A.1
Affiliation:
1. St. Petersburg State University 2. Russian Research Institute of Hematology and Transfusiology of the FMBA of Russia
Abstract
Multiple myeloma and chronic lymphocytic leukemia are oncological diseases of the blood, which remain incurable today. The paper proposes a method for classifying blood serum samples from patients with multiple myeloma, chronic lymphocytic leukemia and healthy donors based on the analysis of their spectra in the mid-infrared (IR) range. IR spectra of blood serum were recorded using a Tensor 27 IR Fourier spectrometer in D2O solution. To analyze the obtained spectra in this work, a machine learning algorithm was implemented – the principal component analysis. The use of the principal component analysis made it possible to significantly simplify the representation of the array of spectral data. 45 samples of blood serum were analyzed in the work. As a result of applying this approach, the studied set of samples is divided into three disjoint sets corresponding to blood serum samples of patients with multiple myeloma, chronic lymphocytic leukemia and healthy donors. Thus, the principal component method can be successfully applied to classify blood serum samples of patients with diagnoses of multiple myeloma and chronic lymphocytic leukemia. The universality of the proposed algorithm allows us to expect that in the future it is possible to apply a similar approach for other oncohematological diseases.
Publisher
RIOR Publishing Center
Reference10 articles.
1. Barlogie B., Gale R.P. Multiple Myeloma and Chronic Lymphocytic Leukemia: Commonalities and Differences in Biology and Therapy. Leukemia & Lymphoma, 1991, vol. 5, no. 1, pp. 27-32., Barlogie B., Gale R.P. Multiple Myeloma and Chronic Lymphocytic Leukemia: Commonalities and Differences in Biology and Therapy. Leukemia & Lymphoma, 1991, vol. 5, no. 1, pp. 27-32. 2. Raab M.S., Podar K., Breitkreutz I., Richardson P.G., Anderson K.C. Multiple myeloma. 2009, vol. 374, 16 p., Raab M.S., Podar K., Breitkreutz I., Richardson P.G., Anderson K.C. Multiple myeloma. 2009, vol. 374, 16 p. 3. Mikhailets E.S., Chernyshev D.A., Telnaya E.A., Plotnikova L.V., Garifullin A.D., Kuvshinov A.Yu., Voloshin S.V., Polyanichko A.M. Protein secondary structure analysis of serum from patients with oncohematological diseases. Journal of Physics: Conference Series, 2021, vol. 2103, p. 012053, doi: 10.1088/1742-6596/2103/1/012053., Mikhailets E.S., Chernyshev D.A., Telnaya E.A., Plotnikova L.V., Garifullin A.D., Kuvshinov A.Yu., Voloshin S.V., Polyanichko A.M. Protein secondary structure analysis of serum from patients with oncohematological diseases. Journal of Physics: Conference Series, 2021, vol. 2103, p. 012053, doi: 10.1088/1742-6596/2103/1/012053. 4. Тельная Е.А., Плотникова Л.В., Гарифуллин А.Д., Кувшинов А.Ю., Волошин С.В., Поляничко А.М. Инфракрасная спектроскопия сыворотки крови больных онкогематологическими заболеваниями. Санкт-Петербургский государственный университет. Биофизика, 2020, т. 65, № 6, с. 1154-1160., Telnaya E.A., Plotnikova L.V., Garifullin A.D., Kuvshinov A.Yu., Voloshin S.V., Polyanichko A.M. Infrared spectroscopy of blood serum of patients with oncohematological diseases. St. Petersburg State University. Biophysica, 2020, vol. 65, no. 6, pp. 1154-1160. (In Russ.) 5. Dunn K. Process Improvement Using Data, 2010., Dunn K. Process Improvement Using Data, 2010.
|
|